top of page
Group 1.png
Pipeline_PC.png
​파이프라인

Pipeline

SCROLL DOWN

파이프라인

PROTIER Biotech 은 혁신적인 바이오 기술을 바탕으로 다양한 치료제를 개발하고 있습니다.

Contenes.png
PTB600
TARGET
GSPT1
INDICATION
Solid tumor
Hematologic malignancy
MODALITY
MG
DRUG CANDIDATE
Discovery
Candidate
Pre-clinical
f2f55568a7abdd4292e5cda103d57f0f4600a35e.png
Program
PTB700
TARGET
GSPT1
INDICATION
Multiple Myeloma
MODALITY
ADC Payload
(MG)
DRUG CANDIDATE
Discovery
Candidate
Pre-clinical
Clip path group.png
Program
PTB500
TARGET
Undisclosed
(First-in-class)
INDICATION
Ovarian cancer
MODALITY
MG
DRUG
Discovery
Candidate
Pre-clinical
f7d83d9bcae79ed8083b941079d649d5fd6e5b76.png
Program
Discovery Target
TARGET
Undisclosed
(First-in-class)
Undisclosed
(First-in-class)
Undisclosed
INDICATION
Undisclosed
Undisclosed
Undisclosed
MODALITY
MG
MG
MG
DRUG
Discovery
Candidate
Pre-clinical
Program

PTB600

TARGET

GSPT1

INDICATION

Solid tumor Hematologic malignancy

MODALITY

MG

DRUG CANDIDATE

Candidate

PROGRAM

image 20

PTB700

TARGET

GSPT1

INDICATION

Multiple Myeloma

MODALITY

ADC Payload (MG)

DRUG CANDIDATE

Discovery

PROGRAM

Untitled.png

PTB500

TARGET

Undisclosed(First-in-class)

INDICATION

Ovarian Cancer

MODALITY

MG

DRUG CANDIDATE

Candidate

PROGRAM

image 18

Discovery Target

TARGET

Undisclosed(First-in-class)

INDICATION

Undisclosed (3)

MODALITY

MG

DRUG CANDIDATE

Discovery

bottom of page